US BANCORP \DE\ - AILERON THERAPEUTICS INC ownership

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of AILERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$5,000
-28.6%
25,0000.0%0.00%
Q2 2022$7,000
-46.2%
25,0000.0%0.00%
Q1 2022$13,000
-7.1%
25,0000.0%0.00%
Q4 2021$14,000
-46.2%
25,0000.0%0.00%
Q3 2021$26,000
-16.1%
25,0000.0%0.00%
Q2 2021$31,000
-13.9%
25,0000.0%0.00%
Q1 2021$36,000
+38.5%
25,0000.0%0.00%
Q4 2020$26,000
-18.8%
25,0000.0%0.00%
Q3 2020$32,000
+6.7%
25,0000.0%0.00%
Q2 2020$30,000
+275.0%
25,0000.0%0.00%
Q1 2020$8,000
-42.9%
25,0000.0%0.00%
Q4 2019$14,000
-17.6%
25,0000.0%0.00%
Q3 2019$17,000
-5.6%
25,0000.0%0.00%
Q2 2019$18,00025,0000.00%
Other shareholders
AILERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 16,609,449$16,942,00011.60%
AJU IB Investment Co., Ltd. 517,558$528,0000.34%
BVF INC/IL 5,265,555$5,371,0000.21%
Ikarian Capital, LLC 2,763,583$2,818,0000.20%
Game Plan Financial Advisors, LLC 127,000$130,0000.08%
PVG ASSET MANAGEMENT CORP 23,555$24,026,0000.07%
MORGAN JESS S & CO INC 75,000$76,0000.05%
Virtu Financial LLC 180,933$185,0000.02%
Keebeck Wealth Management, LLC 76,000$78,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 312,325$319,0000.01%
View complete list of AILERON THERAPEUTICS INC shareholders